Searched for
PHARMA STOCKS
F&O Talk: 23,270 is a key Nifty hurdle; Sudeep Shah picks 5 stocks, discusses PB Fintech, Turtlemint strategyNifty ended at 23,140.50 after an eighth consecutive weekly decline, with technical indicators remaining bearish. Analysts identify 23,300 ...
Nifty at key 23,000 support: Can bulls trigger a technical rebound?Nifty extended its losing streak to seven weeks, falling 0.88% to 23,140.50 as technical momentum remained bearish. The 23,000–23,200 zone ...
Market wrap: Axis Bank, Asian Paints, Max Healthcare, Infosys top gainers and losers on Nifty and Sensex on FridayIndian equity benchmarks ended higher on Friday, with the Nifty 50 rising 0.34% and the Sensex gaining 0.43%. Axis Bank and Asian Paints le...
Sensex rises 315 points, Nifty closes above 23,100 as market recovers some losses a day after crash. What lies ahead?On Friday, the Indian stock market made a comeback, with Sensex rising by 315 points to close at 73,896 and Nifty gaining 77 points to reac...
Ahead of Market: 10 things that will decide stock market action on FridayIndian equities suffered a sharp selloff, with Sensex plunging 1,248 points and Nifty falling 1.6% as US Treasury yields hit 19-year highs,...
Jagsonpal Pharma to acquire Group Pharma’s wellness portfolioJagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisit...
Sensex jumps 299 points, Nifty closes near 23,450 as oil dips below $99/barrel. What can trigger the next sharp rally on D-Street?The Indian stock market closed positively on Wednesday, with Sensex climbing over 299 points to stand at 74,828, and Nifty gaining roughly ...
CAS chaos: Nifty’s indicative price drops 1% in seconds to fall below 23,150 on F&O expiry day, Sensex closes 330 pts lowerIndian equities ended lower on Tuesday after morning gains faded, with Sensex dropping 330 points and Nifty witnessing a sharp closing-auct...
Helios Flexi Cap Fund trims exposure in HDFC Bank, RIL, 2 more stocks; hikes stake in Swiggy, Paytm and 26 othersHelios Flexi Cap Fund reshuffled its portfolio in August, cutting exposure to HDFC Bank, Reliance Industries and other holdings while addin...
MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
Cohance Lifesciences among 5 stocks showing RSI trending upFive Nifty500 stocks were highlighted in the RSI Trending Up scan on September 21, based on data from StockEdge. Mankind Pharma, Cohance Li...
Engineers India among 4 stocks showing White Marubozu patternFour Nifty500 stocks appeared on the White Marubozu bullish scanner on September 21, according to StockEdge’s technical scan data. Engineer...
Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities gained on Monday as cooling oil prices and positive global cues lifted sentiment. Sensex rose 564 points to 74,859, while N...
Why did market rise today? Sensex jumps 564 pts, Nifty closes above 23,400. 4 key factors driving the surgeIndian stock markets saw gains on Monday, with Sensex and Nifty rising. Cooling oil prices and strong global cues boosted investor sentimen...
Nifty outlook: Can the index defend the crucial 23,000 level?The Nifty index has extended its losing streak, testing key support levels. Recent recovery indicates demand, but the broader trend remains...
Gland Pharma and CAMS among 5 smallcap stocks sold by mutual funds in AugustGland Pharma, LIC Housing Finance, Gujarat Energy, CAMS and Amber Enterprises India saw the highest mutual fund selling among smallcap stoc...
Two Trades for Today: A mid-cap pharma stock for a 5.3% upmove, a capital goods manufacturer for an almost 7% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
Global Market: Nikkei gains as investors snap up gaming, pharma stocksJapan’s Nikkei edged higher as investors bought beaten-down gaming and pharmaceutical shares, while falling crude oil prices supported sent...
MFs turn selective, pick Coal India, LIC among large-caps in AugustAmid the backdrop of increasing US interest rates in August, fund managers proceeded with caution, prioritizing large-cap stocks that offer...
JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...